Idiopathic Sudden Sensorineural Hearing Loss

HBOT for ISSNHL

Hyperbaric Oxygen Therapy for Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) is a specialized treatment targeting inner ear tissue recovery through enhanced oxygen delivery. HBOT Supports mitochondrial function in damaged cochlear cells, helps neutralize free radicals, reduces hypoxic damage in inner ear structures, and potentially interrupts inflammatory cascades causing hearing loss.

A healthcare professional using an otoscope to examine an elderly man's ear in a medical setting.

Administering treatment as soon as possible can facilitate the following benefits:

  • Supports mitochondrial function in damaged cochlear cells

  • Helps neutralize free radicals

  • Reduces hypoxic damage in inner ear structures

  • Potentially interrupts inflammatory cascades causing hearing loss

Recommended complementary treatments often include corticosteroids and addressing underlying vascular or autoimmune conditions that might contribute to sudden hearing loss.